By 26 months, 81% of families of children with B-ALL reported job or marital changes; less frequent maintenance pulses eased expenses only.

Nurses and NPs share how they manage rash, stomatitis, diarrhea, dose holds, cost, and trial eligibility with oral daraxonrasib in pancreatic cancer.

As bispecifics and cell therapies move outpatient, Kate Kennedy, MSN, APRN, says nurses and APPs should focus on education ...

A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points ...

A nurse-led educational intervention combining an in-person session and an animated video improved trial-naïve patients' ...

Nicole Doell, MSN, RN, of Sylvester explains how nurses can address breast cancer misinformation without judgment and share ...

Ellery Palanuk, MSN, RN, CN-BN, explains how navigators rely on multidisciplinary teams and tumor boards as breast cancer ...

Daraxonrasib, tarlatamab, an mRNA melanoma therapy and ivonescimab led ESMO 2026. Tell us which findings you can act on now.

The approval covers IV and subcutaneous pembrolizumab and raises the TMB-H threshold from 10 to 13 mutations/megabase.

The American Nurses Association (ANA) has released a new position statement on incivility and bullying in nursing that frames ...

Oncology nurses play a key role guiding patients about AI breast cancer risk assessment tools, dynamic re-testing, and ...